Literature DB >> 7311637

Noninvestigational use of unapproved drugs--experience from the Scandinavian countries.

E Hemminki.   

Abstract

In the Scandinavian countries it is possible to use unapproved drugs for treatment purposes with special permission from the drug control authorities (individual licenses). The Scandinavian practice and the problems connected with it are described. The basic principle underlying the laws and regulations has been and is the same in each country: unapproved drugs should be used only in exceptional cases for special reasons. However, the practice has become different: many individual licenses have been granted, giving physicians much greater opportunity to prescribe drugs of their choice than the apparently tight Scandinavian licensing laws and practices would suggest. The great number of individual licenses has become an administrative problem and has also undermined the principle underlying the law.

Mesh:

Year:  1981        PMID: 7311637     DOI: 10.1097/00005650-198110000-00007

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  2 in total

1.  Limited lists of drugs: lessons from abroad.

Authors:  T Smith
Journal:  Br Med J (Clin Res Ed)       Date:  1985-02-16

2.  Less Is More: Norwegian Drug Regulation, Antibiotic Policy, and the "Need Clause".

Authors:  Bård Hobaek; Anne Kveim Lie
Journal:  Milbank Q       Date:  2019-07-21       Impact factor: 4.911

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.